I do agree FGE looks cheap and a good buy at these levels, I think Skaffold can be misleading however as a product.Or at very least one of its main promoters openly contradicts given valuations.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution